Welcome to our dedicated page for Corteva news (Ticker: CTVA), a resource for investors and traders seeking the latest updates and insights on Corteva stock.
Corteva, Inc. reports developments for a global pure-play agriculture company built around seed, crop protection, and digital products and services. News commonly covers quarterly results, demand and productivity trends across its Seed and Crop Protection portfolios, technology pipeline commentary, guidance updates, investor conference participation, and dividend actions on Corteva common stock and preferred stock at its EIDP subsidiary.
Company updates also include board and executive leadership changes, annual meeting outcomes, and strategic separation planning involving Corteva's agriculture businesses. Coverage is centered on the company's role in agricultural inputs, its product innovation, and its global distribution model serving farmers.
Corteva (NYSE: CTVA) announced that its wholly owned subsidiary Vylor has launched private exchange offers for any and all of three EIDP senior note series: 2.300% due 2030 ($500 million outstanding), 5.125% due 2032 ($500 million) and 4.800% due 2033 ($600 million), totaling $1.6 billion.
Eligible holders who tender by the Early Tender Deadline of August 19, 2026 and do not withdraw receive Vylor notes on a par-for-par basis plus cash consideration of $2.50–$5.00 per $1,000, depending on overall participation. Tenders after that deadline but by the Expiration Date of September 3, 2026 receive $970 of Vylor notes per $1,000 of EIDP notes and no cash. Vylor is concurrently soliciting consents to remove most restrictive covenants and certain change-of-control repurchase provisions from the EIDP indentures. The exchange offers are conditioned on receiving requisite consents and on completion of Corteva’s planned separation of its seed business into Vylor, currently expected on or about October 1, 2026.
Corteva (NYSE: CTVA) reported 2Q 2026 GAAP net sales of $6.38 billion (down 1% year over year) and GAAP EPS from continuing operations of $1.81 (down 10%), while non-GAAP Operating EBITDA rose 4% to $2.26 billion and Operating EPS increased 5% to $2.30. For 1H 2026, GAAP net sales grew 4% to $11.28 billion, with Organic sales up 2%, Operating EBITDA up 10% to $3.70 billion, and Operating EPS up 14% to $3.80.
Seed 1H net sales rose 4% to $7.56 billion with flat volumes and higher price/mix, driving 11% Operating EBITDA growth and ~235 bps margin expansion. Crop Protection 1H net sales increased 3% to $3.73 billion, with 9% Operating EBITDA growth and ~120 bps margin expansion despite price pressure, mainly in Latin America.
According to Corteva, full-year 2026 guidance was raised, now targeting Operating EBITDA of $4.1–$4.3 billion and Operating EPS of $3.60–$3.80. The company also confirmed it remains on track to complete the planned separation and spin off Vylor on October 1, 2026, with about $25 million of net dis-synergy headwind included in 2026 guidance.
Corteva (NYSE: CTVA) declared a common stock dividend of $0.18 cents per share, payable on September 15, 2026 to shareholders of record as of September 1, 2026. The Board of EIDP, a wholly owned Corteva subsidiary, also declared regular preferred dividends on its $4.50 and $3.50 series, payable October 23, 2026 to holders of record on October 2, 2026.
Corteva (NYSE: CTVA) named the intended nine-member board for its future standalone, publicly traded crop protection company, planned for separation in 4Q 2026. Greg Page will serve as independent chair. Most current directors remain with Corteva, while Luke Kissam joins as future CEO and director.
Corteva (NYSE:CTVA) named the initial board of directors for Vylor, its planned advanced seed and genetics spin-off. Karen Grimes will serve as independent chair. Seven directors are appointed, with a search underway for at least one more.
The board will become effective at separation, which remains targeted for Q4 2026. Vylor aims to use elite germplasm, biotech, gene editing and molecular breeding to strengthen core seed businesses, expand into new row crops and grow its licensing operations.
FMC (NYSE:FMC) and Corteva announced a co-exclusive strategic supply and license agreement for rimisoxafen, covering corn and soybean markets in North and South America through the next decade.
FMC keeps ownership, supplies the active ingredient, receives a $200 million prepurchase payment, and targets first sales by decade-end, pending approvals.
Corteva (NYSE:CTVA) announced that CFO David Johnson and Chief Technology and Digital Officer Sam Eathington will present at Wolfe's third annual Materials of the Future Conference at 8:35 a.m. ET on June 17, 2026. The remarks will be webcast live with a replay available until September 17, 2026.
Corteva (NYSE: CTVA) will release its second quarter 2026 earnings on Thursday, July 30, 2026 after market close via press release and its website.
A live earnings webcast is scheduled for Friday, July 31, 2026 at 9:00 a.m. ET, with replay access available until July 31, 2027.
Corteva (NYSE: CTVA) announced that after its planned separation in Q4 2026, its two future companies will have distinct headquarters. New Corteva, focused on crop protection and nature-inspired technologies, will be based in Indianapolis, Indiana, while Vylor, its advanced seed and genetics business, will be headquartered in Johnston, Iowa.
New Corteva will keep a Global Corporate Business Center in Wilmington, Delaware. Vylor, anchored by the Pioneer brand and biotechnology capabilities, will maintain a Global Corporate Business Center in Southeast Pennsylvania.
Corteva (NYSE: CTVA) announced that CEO Chuck Magro and EVP & CFO David Johnson will speak at the 2026 BMO Global Farm to Market conference on May 14, 2026 at 11:00 a.m. EDT. Remarks will be webcast live and a replay will be available 24 hours after the presentation, accessible until August 14, 2026.